Dexcom Inc. Stock
Price
Target price
€70.94
€70.94
0.230%
0.16
0.230%
€89.23
08:00 / Tradegate
WKN: A0D9T1 / Symbol: DXCM / Name: DexCom / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Dexcom Inc. Stock
Dexcom Inc. gained 0.230% compared to yesterday.
The stock is an absolute favorite of our community with 27 Buy predictions and no Sell predictions.
With a target price of 89 € there is a positive potential of 25.46% for Dexcom Inc. compared to the current price of 70.94 €.
Our community identified positive and negative aspects for Dexcom Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Dexcom Inc. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Dexcom Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dexcom Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dexcom Inc. | 0.230% | -4.066% | -4.468% | 12.977% | -6.252% | -11.856% | -23.481% |
| Henry Schein Inc. | -1.510% | -3.983% | -4.355% | -10.773% | -11.121% | -23.107% | 1.628% |
| Teleflex Inc. | 4.080% | 1.538% | 0.000% | -50.990% | -41.071% | -56.957% | -68.868% |
| Baxter International | 0.570% | -22.198% | -25.891% | -42.451% | -31.563% | -66.819% | -74.027% |
Comments
DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Raymond James Financial, Inc. from $99.00 to $102.00. They now have a "strong-buy" rating on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Piper Sandler from $90.00 to $100.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at UBS Group AG from $105.00 to $106.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
News
DexCom (DXCM) Q2 Revenue Jumps 15%
DexCom (NASDAQ:DXCM) reported its second-quarter 2025 results on July 30, 2025, delivering an upbeat performance highlighted by a revenue beat and continued expansion in the key type 2 diabetes
Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2025.
Second Quarter 2025 Financial Highlights:
-
Revenue grew 15% year-over-year to
Why This Beaten-Down Medical Device Stock Could Be Your Best Investment for the Next 5 Years
Medical device specialist DexCom (NASDAQ: DXCM) has encountered significant headwinds in the past year. The company's financial results haven't been quite up to the market's standards, and broader